News

Filter

Current filters:

CopaxoneSandoz

1 to 9 of 14 results

Court ruling favors Mylan in Copaxone patent dispute

17-07-2013

A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Teva files patent suit against Novartis over Copaxone

08-09-2008

Israeli generics giant Teva has filed a patent infringement suit against Swiss drug major Novartis' generic…

CopaxoneGlatiramer AcetateNovartisSandoz

Momenta Pharma sets priority on launch of M-Enoxaparin, as losses narrow

07-04-2008

The US biotechnology industry includes about 1,000 firms, with combined annual revenue close to $50.0…

Aventis PharmaCopaxoneEnoxaparin Sodium InjectionGlatiramer AcetateLovenoxNovartisSandozSanofi-Aventis

1 to 9 of 14 results

Back to top